AVB
15
6
TROW
31
7
NWL
64
3
ABT
36
4
WDC
65
5
EQT
65
6
AIZ
73
2
ROK
62
2
M
65
12
THC
52
3
ZION
71
6
IVZ
46
6
FAST
55
2
ESS
28
8
CCL
79
11
IFF
60
3
ETN
73
8
WFC
63
3
ORLY
49
2
EIX
64
2
AVB
15
6
TROW
31
7
NWL
64
3
ABT
36
4
WDC
65
5
EQT
65
6
AIZ
73
2
ROK
62
2
M
65
12
THC
52
3
ZION
71
6
IVZ
46
6
FAST
55
2
ESS
28
8
CCL
79
11
IFF
60
3
ETN
73
8
WFC
63
3
ORLY
49
2
EIX
64
2
Financhill
Back

Vistagen Therapeutics, Inc. Stock Predictions

1.5 Million Users. Zero Hype. Still Private.

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
16

VTGN
Vistagen Therapeutics, Inc.

Last Price:
$0.56
Seasonality Move:
-11.81%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Phase of AI Is Not About Chat

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com

Vistagen Therapeutics, Inc. Stock Forecast

  • Is Vistagen Therapeutics, Inc. Stock Undervalued?
    The current Vistagen Therapeutics, Inc. [VTGN] share price is $0.56. The Score for VTGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • VTGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Vistagen Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Vistagen Therapeutics, Inc. Stock Rating

Data Unavailable

Vistagen Therapeutics, Inc. Stock Price History

Is VTGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vistagen.com

52-Week Data

52-Week High:
5.14
52-Week Low:
0.50

Prediction Charts

Market Cap:
22.2M
Price in USD:
0.56
Volume:
1.7M
Beta:
-0.37

Technical Analysis

SMA50:
1.84
SMA100:
2.86
SMA200:
2.74
52-Wk Change:
-80.38%

Stock Predictions

  • Is Vistagen Therapeutics, Inc. stock public?
    Yes, Vistagen Therapeutics, Inc. is a publicly traded company.
  • What is the Vistagen Therapeutics, Inc. stock quote today?
    The Vistagen Therapeutics, Inc. stock price is 0.56 USD today.
  • How to buy Vistagen Therapeutics, Inc. stock online?
    You can buy Vistagen Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-20 0.65 0.65 0.66 0.64
Jan-21 0.65 0.63 0.66 0.62
Jan-22 0.64 0.66 0.68 0.64
Jan-23 0.66 0.65 0.66 0.64
Jan-26 0.64 0.62 0.65 0.62
Jan-27 0.63 0.61 0.63 0.60
Jan-28 0.61 0.59 0.62 0.58
Jan-29 0.57 0.54 0.58 0.54
Jan-30 0.54 0.56 0.57 0.54
Feb-2 0.56 0.58 0.60 0.56
Feb-3 0.58 0.54 0.60 0.54
Feb-4 0.55 0.53 0.56 0.51
Feb-5 0.52 0.51 0.54 0.50
Feb-6 0.51 0.56 0.57 0.50

Vistagen Therapeutics, Inc. Earnings

Data Unavailable

Vistagen Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.60 per share.

* Vistagen Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.